Oncology innovation is accelerating across therapeutic modalities, precision medicine, biomarkers and artificial intelligence. But as scientific possibilities expand, the growing challenge for sponsors is determining what is ready to move forward and how to make critical oncology drug development decisions with greater confidence.
Increasingly, that means evaluating not only scientific promise, but whether innovations can be scaled across geographies, complex patient populations and regulatory environments to support successful global clinical development programs. This webinar will examine how to assess which advances are development-ready and translate them into scalable global strategies.
Ahead of the 2026 European Society for Medical Oncology (ESMO) Congress, Syneos Health® surveyed the oncology community to understand where leaders see the greatest opportunities and challenges in oncology clinical development. Responses highlighted strong interest in emerging scientific advances while reinforcing the need for practical guidance on trial design, execution and development strategy.
That reflects a broader industry reality: breakthrough science is advancing rapidly, but sponsors must still determine which innovations are ready to scale and how to translate scientific promise into clinical development and commercial impact.
That tension will anchor this webinar.
Following a brief, data-led presentation, oncology experts will examine what separates promising oncology innovation from development-ready science, and what it takes to translate emerging breakthroughs into scalable clinical trial and drug development strategies.
The conversation will look beyond individual ESMO readouts to ask a more consequential question: Which advances are truly ready to move oncology drug development forward, and what should sponsors be doing now to accelerate their impact?
Register for this webinar to learn how oncology drug development strategies can help translate emerging science into scalable global clinical programs.
Speakers
Catarina Ribeiro, MD, Senior Medical Director, Oncology, Syneos Health
Catarina Ribeiro, MD, is Senior Medical Director, Oncology at Syneos Health, bringing medical and scientific expertise to oncology clinical development and clinical trials. Her work spans hematology and oncology, with interests including cancer treatment outcomes, body composition and the evolving science shaping oncology drug development. She contributes to Syneos Health thought leadership on emerging trends in cancer research and precision oncology.
Message Presenter
Alberto Puccini, MD, Medical Oncologist, IRCCS Humanitas Research Hospital, Humanitas Cancer Center
Alberto Puccini, MD, is a Medical Oncologist at IRCCS Humanitas Research Hospital and Assistant Professor at Humanitas University in Milan, Italy. His clinical and research work focuses on gastrointestinal cancers, including colorectal cancer, cancer biomarkers and translational oncology. He has contributed extensively to research exploring precision medicine, molecular profiling and emerging treatment strategies in gastrointestinal oncology.
Message Presenter
Martin Forster, MD, Associate Professor of Medical Oncology, University College London and Consultant Medical Oncologist, University College Hospital
Martin Forster, MD, is an Associate Professor at University College London and Consultant Medical Oncologist at University College Hospital. Specializing in thoracic and head and neck cancers, he has extensive expertise in oncology drug development, precision medicine and clinical trials. He has served as Principal or Chief Investigator across numerous early- and late-phase studies, including first-in-human trials, immunotherapy studies and Phase III research.
Message Presenter
Paul Nathan, MBBS, PhD, FRCP, Consultant Medical Oncologist, Mount Vernon Cancer Centre
Paul Nathan, MBBS, PhD, FRCP, is a Consultant Medical Oncologist at Mount Vernon Cancer Centre in the UK, specializing in malignant melanoma and renal cell carcinoma. He has extensive experience in cancer research and oncology clinical trials, serving as a Chief Investigator, steering committee member and data monitoring committee member for academic and industry-sponsored studies. He also has particular expertise in uveal melanoma.
Message PresenterWho Should Attend?
This webinar will appeal to:
- Chief Medical Officers
- Chief Development Officers
- Heads and VP/SVPs of Clinical Development
- Heads of Oncology R&D
- Clinical Development Leaders
- Disease Area Strategy Leads
- Clinical Operations Leaders
- Medical Monitors
- Clinical Scientists
- Translational Medicine and Biomarker Leaders
- Precision Oncology Teams
- Clinical Trial Managers
What You Will Learn
Attendees will leave the webinar with a clearer understanding of:
- Make critical oncology development decisions earlier and with greater confidence, using emerging evidence, biomarkers, dose optimization and adaptive approaches to inform the path to proof of concept
- Separate practical predictive intelligence from AI hype, identifying where AI, multimodal data and biomarkers can meaningfully inform tumor selection, patient identification and clinical development strategy
- Scale increasingly complex oncology science across global clinical development programs, from emerging innovation hubs and precision medicine approaches to trial design, regulatory alignment and global execution
Xtalks Partner
Syneos Health
Syneos Health® is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. They translate unique clinical, medical affairs and commercial insights into outcomes to address modern market realities. Together they share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients. They support a diverse, equitable and inclusive culture.
To learn more about how we are shortening the distance from lab to life®, visit syneoshealth.com or subscribe to our podcast.
You Must Login To Register for this Free Webinar
Already have an account? LOGIN HERE. If you don’t have an account you need to create a free account.
Create Account